Rapid diagnostic test kit for detection of tumor-associated antigens in blood or tissue samples. Aids in cancer screening and oncology monitoring.
Manufactured by
China
Changchun Wancheng Bio-electron Co., Ltd. was established in 2002 with a registered capital of 20 million yuan. It is a national high-tech enterprise engaged in the R&D, production and sales of in-vitro diagnosis and family health testing projects. We have a modern diversified production and R&D base equipped with advanced technology and facilities.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Lansion Biotechnology Co., Ltd.
China · 3 relevant products
AEHEALTH Limited
China · 1 relevant product
BioTeke Corporation(wuxi) Co.,Ltd
China · 1 relevant product
InTec PRODUCTS, INC.
China · 3 relevant products
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 3 relevant products
Nantong Egens Biotechnology Co., Ltd.
China · 1 relevant product
AVE Science & Technology Co.,Ltd.
China · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 3 relevant products
Beijing Hotgen Biotech Co.,Ltd
China · 2 relevant products
Fujirebio Diagnostics,Inc.
China · 3 relevant products
83 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 116 closest product alternatives
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for oncology marker detection. Enables rapid assessment of cancer-related biomarkers.
AEHEALTH Limited · China
In vitro diagnostic reagent for detection and measurement of tumor markers in patient specimens. Supports oncology screening and monitoring applications.
BioTeke Corporation(wuxi) Co.,Ltd · China
Immunoassay-based test for rapid detection of tumor-associated markers in clinical samples. Supports oncology screening and cancer diagnostics in clinical laboratories.
InTec PRODUCTS, INC. · China
Rapid immunochromatographic assay for qualitative detection of tumor marker antigens. Point-of-care diagnostic test for cancer screening and monitoring.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening diagnostic assays that detect key oncology markers including AFP, CEA, PSA, and FOB with low sample volume requirements. Designed to facilitate accessible early-stage risk stratification and are ideal for large-scale population health screening programs.
Nantong Egens Biotechnology Co., Ltd. · China
In vitro diagnostic kits for detection and quantification of cancer biomarkers in patient samples. Available in multiple formats including ELISA and CLIA for oncology applications.
AVE Science & Technology Co.,Ltd. · China
Reagent system for measuring tumor-associated antigens in patient samples. Supports cancer screening and treatment monitoring.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
In vitro diagnostic test for identifying and quantifying cancer-related biomarkers. Supports oncology diagnosis, prognosis, and treatment monitoring.
Beijing Hotgen Biotech Co.,Ltd · China
ELISA-based diagnostic kit for tumor marker detection and quantification. Supports cancer screening and monitoring in laboratory settings.
Fujirebio Diagnostics,Inc. · China
A comprehensive tumor marker product line with complete project coverage, simple experimental procedures, and convenient operation. The detection results are accurate and stable for in vitro diagnostics.
Vitrotest Bioreagent LLC · Ukraine
ELISA test kit for the quantitative determination of tumor markers in human serum or plasma. Supports oncology laboratory diagnostics and cancer screening.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
Rapid screening assays for AFP, CEA, PSA, and other key oncology markers enabling accessible, early-stage risk stratification in community health screening and specialist oncology settings. Offers quantitative fluorescence and semi-quantitative formats with low sample volume requirements of 50–100 µL serum/plasma. Multi-marker combo panels are available.
104 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products